"GLISAXAPIN M 5/500: Dual Control for Diabetes"

GLISAXAPIN M 5/500 

 Saxagliptin (5mg), Metformin HCI (ER) (500mg)

Introduction to GLISAXAPIN M 5/500

GLISAXAPIN M 5/500 is a potent combination medication designed to manage blood sugar levels in individuals with type 2 diabetes. This pharmaceutical marvel combines the power of Saxagliptin (5mg) and Metformin HCI (ER) (500mg) to provide a dual approach to diabetes management, enhancing glycemic control while minimizing side effects.

Saxagliptin (5mg) in GLISAXAPIN M 5/500

Saxagliptin, a key component of GLISAXAPIN M 5/500, is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by enhancing the levels of incretin hormones, which help to regulate blood sugar by increasing insulin release and decreasing glucagon levels in the blood.

Usage and Benefits

• Enhances Insulin Production: Saxagliptin increases insulin production in response to high blood glucose levels.
• Lowers Blood Sugar: Helps in reducing fasting and postprandial blood sugar levels.
• Weight Neutral: Unlike some diabetes medications, Saxagliptin does not contribute to weight gain.

Metformin HCI (ER) (500mg) in GLISAXAPIN M 5/500

Metformin HCI (Extended Release) forms the second pillar of GLISAXAPIN M 5/500, acting primarily by decreasing glucose production in the liver and improving the body's sensitivity to insulin.

Usage and Benefits

• Extended Blood Sugar Control: The extended-release formula ensures steady blood sugar control throughout the day.
• Reduces Glucose Production: Limits the liver's production of glucose, preventing blood sugar spikes.
• Improves Insulin Sensitivity: Enhances the body’s response to insulin, aiding in the effective utilization of glucose.

Comprehensive Benefits of GLISAXAPIN M 5/500

By combining Saxagliptin and Metformin HCI (ER), GLISAXAPIN M 5/500 offers a synergistic effect that provides robust benefits for individuals with type 2 diabetes:

• Dual Action Control: Targets multiple pathways in the body to improve blood sugar regulation.
• Sustained Efficacy: Offers consistent and long-lasting control of blood glucose levels.
• Minimized Side Effects: The combination of ingredients often leads to fewer side effects compared to using each drug individually.

Conclusion

GLISAXAPIN M 5/500 stands out as a comprehensive solution for the effective management of type 2 diabetes. Its innovative combination of Saxagliptin and Metformin HCI (ER) addresses the key aspects of diabetes control, providing a stable, effective, and convenient treatment option. With GLISAXAPIN M 5/500, individuals can achieve better glycemic control, leading to an improved quality of life and reduced risk of diabetes-related complications.  A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668   

  BUY NOW